PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1961 April; 54(4): 259–261.
PMCID: PMC1870342

The Clinical Application of Aldosterone Antagonists in the Treatment of Œdema

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (469K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • KERR DN, READ AE, HASLAM RM, SHERLOCK S. The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis. Lancet. 1958 Nov 22;2(7056):1084–1087. [PubMed]
  • LIDDLE GW. Aldosterone antagonists. AMA Arch Intern Med. 1958 Dec;102(6):998–1004. [PubMed]
  • READ AE, HASLAM RM, LAIDLAW J, SHERLOCK S. Chlorothiazide in control of ascites in hepatic cirrhosis. Br Med J. 1958 Apr 26;1(5077):963–966. [PMC free article] [PubMed]
  • SHALDON S, McLAREN JR, SHERLOCK S. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide). Lancet. 1960 Mar 19;1(7125):609–613. [PubMed]
  • DAWSON AM, SHERLOCK S, SUMMERSKILL WH. The treatment and prognosis of hepatic coma. Lancet. 1956 Oct 6;271(6945):689–694. [PubMed]
  • SLATER JD, MOXHAM A, HURTER R, NABARRO JD. Clinical and metabolic effects of aldosterone antagonism. Lancet. 1959 Nov 28;2(7109):931–934. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press